STOCKSURGICAL & MEDICAL INSTRUMENTS & APPARATUSUpdated 2026-05-24
Here’s whether Glaukos Corporation (GKOS) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); 50-day MA is rising (+4.76% over 10 days); strong 1-year return of +23.7%; rising volume confirms the move (1.18x 30d avg). Concerns: below the 50-day MA (medium-term momentum negative). Currently 18.8% off its 52-week high. Score: +4/7.
GKOS is holding above its long-term 200-day MA ($105.29) but has slipped below the 50-day MA ($121.51), pointing to short-term weakness in an otherwise intact trend. An RSI of 33.8 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +23.7% compares to +27.9% for SPY (trailed the market by 4.2%).
$10,000 invested 1 year ago→ $12,371 today
vs. S&P 500 (SPY) — same period trailed market by 4.2%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($105.29)
✗Above 50-day MA ($121.51)
✓RSI(14) neutral zone (30–70) — currently 33.8
✓Positive return (+23.7%)
!Within 10% of period high (−18.8%)
Period Range $120.23
$73.16$148.11
RSI (14) 33.8
0 · OversoldOverbought · 100
Key Metrics
Price$120.23
Period Return+23.7%
Period High$148.11
Period Low$73.16
Drawdown−18.8%
MA-50$121.51
MA-200$105.29
RSI (14)33.8
Avg Volume (30d)850K
vs. SPYtrailed by 4.2%
Return Rank#532 of 1236
Trend Signals
Price is above the 200-day moving average ($105.29)
Price is below the 50-day moving average ($121.51)